cervic
cancer
one
common
cancer
women
worldwid
persist
infect
human
papillomaviru
hpv
consid
etiolog
factor
cervic
cancer
therefor
effect
vaccin
hpv
infect
may
lead
control
cervic
cancer
ideal
hpv
vaccin
aim
gener
humor
immun
respons
prevent
new
infect
well
cellmedi
immun
elimin
establish
infect
hpvrelat
diseas
current
studi
gener
potenti
prevent
therapeut
hpv
dna
vaccin
use
human
calreticulin
crt
link
earli
protein
late
protein
found
vaccin
dna
vaccin
induc
potent
cell
immun
respons
result
signific
therapeut
effect
express
tumor
cell
addit
vaccin
dna
gener
signific
neutral
antibodi
respons
protect
pseudovirion
infect
thu
dna
vaccin
capabl
gener
potent
prevent
therapeut
effect
vaccin
mice
data
signific
clinic
implic
cervic
cancer
nd
lead
caus
cancer
death
women
worldwid
primari
factor
develop
cervic
cancer
infect
human
papillomaviru
hpv
hpv
one
common
sexual
transmit
diseas
world
known
cervic
cancer
consequ
persist
infect
highrisk
type
hpv
hpv
infect
necessari
factor
develop
mainten
cervic
cancer
thu
effect
vaccin
hpv
repres
opportun
control
cervic
cancer
vaccin
could
implement
prevent
infect
gener
neutral
antibodi
prevent
vaccin
elimin
infect
induc
virusspecif
cellular
respons
therapeut
vaccin
current
strategi
develop
safe
effect
prevent
vaccin
base
induct
neutral
antibodi
major
minor
capsid
protein
human
papillomaviru
newli
licens
prevent
hpv
vaccin
gardasil
vaccin
remark
safeti
profil
clinic
efficaci
hpv
genotyp
deriv
howev
gardasil
like
effect
subset
hpv
genotyp
type
therefor
provid
complet
protect
cervic
cancer
altern
approach
minor
capsid
protein
arisen
possibl
target
vaccin
develop
importantli
vaccin
induc
broadli
crossneutr
antibodi
mediat
broader
protect
signific
advantag
vaccin
thu
approach
emerg
promis
candid
develop
broadli
protect
vaccin
howev
prevent
hpv
vaccin
unlik
effect
elimin
preexist
infect
hpvrelat
diseas
import
issu
sinc
consider
burden
hpv
infect
worldwid
thu
order
acceler
effect
vaccin
incid
cervic
cancer
help
current
infect
patient
essenti
continu
effort
develop
therapeut
vaccin
choic
target
antigen
extrem
import
design
therapeut
vaccin
sinc
hpvencod
essenti
transform
coexpress
hpvassoci
lesion
review
see
protein
repres
ideal
target
develop
hpv
therapeut
vaccin
ideal
hpv
vaccin
abl
gener
humor
cellmedi
immun
prevent
new
infect
well
elimin
establish
infect
hpvrelat
diseas
therefor
prevent
therapeut
hpv
vaccin
target
earli
protein
hpv
late
antigen
induc
hpv
neutral
antibodi
therapeut
cellular
immun
combin
approach
could
potenti
implement
higher
efficaci
vaccin
could
potenti
prevent
cervic
cancer
treat
hpv
infect
hpvassoci
lesion
dna
vaccin
pose
attract
approach
hpv
vaccin
develop
dna
vaccin
gener
effect
ctl
antibodi
respons
deliv
foreign
antigen
apc
stimul
cell
compar
live
viral
bacteri
vector
nake
dna
plasmid
vaccin
rel
safe
easili
administ
furthermor
dna
vaccin
easi
prepar
larg
scale
high
puriti
high
stabil
engin
express
antigen
peptid
protein
review
see
addit
dna
uniqu
abil
maintain
long
term
episom
form
enabl
prolong
express
antigen
enhanc
immunolog
memori
use
dna
vaccin
express
protein
bypass
mhc
restrict
thu
maintain
higher
ctl
respons
current
protein
vaccin
dna
vaccin
also
repeatedli
appli
patient
safe
effect
unlik
live
vector
vaccin
featur
make
dna
vaccin
potenti
plausibl
approach
hpv
vaccin
develop
dna
consider
advantag
one
major
limit
limit
potenc
due
fact
dna
vaccin
unlik
viral
vector
lack
intrins
abil
amplifi
transfect
cell
use
calreticulin
crt
context
dna
vaccin
repres
promis
approach
enhanc
antigenspecif
cellmedi
immun
respons
well
humor
respons
dna
vaccin
develop
crt
abund
kda
ca
bind
protein
locat
endoplasm
reticulum
er
crt
consid
relat
famili
heat
shock
protein
hsp
protein
shown
associ
peptid
deliv
er
transport
associ
antigen
process
mhc
class
microglobulin
molecul
aid
antigen
present
previous
employ
crtbase
enhanc
strategi
creat
effect
dna
vaccin
use
sarscov
target
antigen
shown
dna
vaccin
encod
calreticulin
crt
link
target
antigen
gener
high
level
antigenspecif
tcell
respons
well
signific
antigenspecif
humor
immun
thu
employ
crt
hpv
dna
vaccin
develop
order
gener
strong
cell
specif
respons
well
humor
respons
hpv
antigen
employ
protein
previous
explor
proteinbas
vaccin
gener
chimer
fusion
protein
also
call
tacin
vaccin
healthi
volunt
tacin
induc
serum
antibodi
neutral
across
papillomaviru
speci
current
studi
creat
hpv
dna
vaccin
encod
calreticulin
link
earli
protein
late
protein
found
vaccin
dna
vaccin
induc
potent
cell
immun
respons
result
signific
therapeut
effect
express
tumor
cell
furthermor
vaccin
gener
signific
neutral
antibodi
respons
pseudovirion
infect
thu
dna
vaccin
capabl
gener
potent
prevent
therapeut
effect
vaccin
mice
clinic
implic
dna
vaccin
discuss
gener
first
amplifi
pcr
use
templat
set
primer
dna
amplifi
codon
modifi
full
length
obtain
dr
muller
clone
vector
amplifi
product
clone
xbainoti
site
vector
nation
gene
vector
laboratori
hcrt
pcr
amplifi
primer
use
human
crt
plasmid
templat
kindli
provid
dr
david
llewellyn
depart
medic
biochemistri
univers
wale
colleg
medicin
cardiff
uk
pcr
product
cut
sal
ieco
ri
clone
sal
ieco
ri
site
codon
optim
enhanc
translat
gene
codon
optim
synthes
genscript
corpor
piscataway
nj
clone
ecorixbai
site
promot
drive
express
vector
cmv
gener
amplifi
anoth
set
primer
pcr
product
cut
ecoribglii
clone
ecoribglii
site
accuraci
dna
construct
confirm
dna
sequenc
variou
gene
amplifi
clone
subsequ
gene
frame
stop
codon
remov
femal
mice
week
old
purchas
nation
cancer
institut
frederick
md
usa
kept
anim
facil
john
hopkin
hospit
baltimor
md
usa
anim
procedur
perform
accord
approv
protocol
accord
recommend
proper
use
care
laboratori
anim
product
mainten
cell
describ
previous
cell
atcc
transient
transfect
plasmid
construct
use
lipofectamin
invitrogen
accord
vendor
manual
cell
grown
co
transfect
express
transfect
gene
cell
character
western
blot
analysi
cell
lyse
mammalian
protein
extract
reagent
mper
pierc
rockford
il
lysat
protein
concentr
determin
spectrophotometri
base
manufactur
instruct
equal
amount
protein
load
separ
sdspage
use
polyacrylamid
gel
blot
onto
nitrocellulos
membran
block
membran
incub
mous
rabbit
antihpv
polyclon
antibodi
room
temperatur
wash
incub
hrpconjug
sheep
antimous
ig
donkey
antirabbit
ig
amersham
bioscienc
uk
respect
membran
detect
chemiluminesc
ecl
kit
amersham
arlington
height
il
gene
gunmedi
intraderm
vaccin
dnacoat
gold
particl
dna
bullet
deliv
shave
abdomin
region
mice
use
heliumdriven
gene
gun
biorad
hercul
ca
usa
discharg
pressur
psi
accord
previous
describ
protocol
mice
vaccin
via
gene
gun
mous
mice
receiv
three
booster
dose
regimen
interv
immedi
dna
vaccin
ugmous
dna
vaccin
deliv
intramuscularli
syring
needl
inject
mice
receiv
three
booster
dose
regimen
interv
cell
surfac
marker
stain
intracellular
cytokin
stain
well
facscan
analysi
perform
use
condit
describ
previous
prior
facscan
splenocyt
differ
vaccin
group
mice
collect
pool
incub
h
peptid
aa
peptid
aa
presenc
golgiplug
detect
tcell
precursor
stimul
splenocyt
wash
twice
facscan
buffer
cell
surfac
marker
stain
intracellular
cytokin
stain
perform
use
condit
describ
previous
number
secret
cell
analyz
use
flow
cytometri
analysi
perform
bectondickinson
facscan
cellquest
softwar
bectondickinson
immunocytometri
system
mountain
view
ca
usa
vivo
tumor
protect
experi
mice
per
group
vaccin
dna
vaccin
gene
gun
inject
twice
interv
one
week
last
vaccin
mice
challeng
tumor
cellsmous
subcutan
inject
right
leg
tumor
growth
monitor
visual
inspect
palpat
twice
week
describ
previous
vivo
tumor
treatment
experi
use
tumor
mice
per
group
intraven
challeng
tail
vein
cell
mous
day
tumor
challeng
mice
administ
via
gene
gun
one
week
first
vaccin
mice
boost
dose
regimen
mice
kill
lung
explant
day
pulmonari
nodul
surfac
lung
mous
count
experiment
blind
sampl
ident
describ
previous
full
length
protein
express
purifi
describ
previous
briefli
codon
modifi
full
length
clone
pet
vector
tag
fusion
protein
express
rosetta
cell
novagen
recombin
protein
purifi
ninta
coumn
denatur
condit
follow
suggest
manufactur
protocol
qiagen
presenc
ab
sera
character
direct
elisa
describ
previous
mice
immun
gene
gun
variou
dna
vaccin
receiv
three
booster
dose
regimen
interv
immedi
dna
vaccin
dna
vaccin
deliv
intramuscularli
syring
needl
inject
mice
receiv
three
booster
dose
regimen
interv
sera
prepar
mice
day
last
immun
pool
full
length
protein
coat
plate
incub
overnight
well
block
pb
contain
bsa
wash
pb
contain
plate
incub
serial
dilut
sera
serum
vaccin
rabbit
full
length
protein
use
posit
control
wash
twice
pb
contain
plate
mix
dilut
hrpconjug
donkey
antirabbit
igg
ab
standard
control
rabbit
antimous
igg
ab
mous
serum
amersham
pharmacia
biotech
piscataway
new
jersey
usa
secondari
antibodi
respect
incub
room
temperatur
hour
elisa
plate
read
standard
elisa
reader
nm
pseudovirion
encapsul
secret
alkalin
phosphatas
seap
gener
cotransfect
cell
plasmid
encod
seap
report
plasmid
describ
previous
buck
et
al
cell
collect
transfect
treat
overnight
brij
benzonas
purifi
centrifug
optiprep
step
gradient
rpm
h
pseudoviru
neutral
assay
carri
outlin
previous
briefli
pseudoviru
pool
mous
immun
sera
incub
h
mixtur
use
infect
cell
h
postinfect
supernat
collect
seap
activ
supernat
measur
colorimetr
assay
serum
neutral
titer
defin
highest
dilut
caus
least
reduct
seap
activ
compar
control
preimmun
serum
sampl
minimum
neutral
would
well
viru
incub
either
prebl
pb
immun
serum
maximum
neutral
would
well
viru
complet
neutral
seap
activ
data
express
mean
repres
least
two
differ
experi
data
intracellular
cytokin
stain
flow
cytometri
analysi
tumor
treatment
experi
analyz
analysi
varianc
anova
comparison
individu
data
point
made
use
student
ttest
kaplan
meier
surviv
curv
tumor
protect
experi
appli
differ
curv
pvalu
calcul
use
logrank
test
valu
p
consid
signific
gener
variou
dna
construct
order
determin
whether
bhk
cell
transfect
recombin
dna
construct
express
encod
gene
andor
perform
western
blot
analysi
cell
lysat
hour
transfect
use
polyclon
antibodi
protein
shown
figur
vaccin
dna
vaccin
express
gener
signific
number
cell
order
assess
level
cell
immun
respons
gener
recombin
dna
vaccin
first
perform
intracellular
cytokin
stain
flow
cytometri
analysi
determin
number
secret
cell
gener
respons
stimul
peptid
mice
per
group
immun
intraderm
via
gene
gun
left
panel
intramuscularli
right
panel
variou
dna
vaccin
splenocyt
vaccin
mice
incub
brestrict
ctl
peptid
aa
overnight
number
cell
determin
shown
figur
signific
number
secret
cell
observ
stimul
peptid
mice
immun
dna
vaccin
express
although
immun
dna
vaccin
express
gener
lower
number
cell
compar
immun
dna
vaccin
express
graphic
represent
number
cell
mice
immun
intraderm
via
gene
gun
intramuscularli
depict
figur
c
respect
addit
data
suggest
immun
via
gene
gun
gener
greater
number
cell
compar
intramuscular
immun
thu
data
indic
mice
immun
dna
vaccin
express
gener
higher
frequenc
activ
cell
compar
control
character
level
cell
immun
respons
gener
recombin
dna
vaccin
use
intracellular
cytokin
stain
flow
cytometri
analysi
splenocyt
vaccin
mice
incub
b
restrict
ctl
peptid
aa
overnight
number
cell
determin
shown
figur
signific
number
secret
cell
observ
stimul
peptid
mice
immun
dna
vaccin
express
although
immun
dna
vaccin
express
gener
lower
number
cell
compar
immun
dna
vaccin
express
graphic
represent
number
cell
mice
immun
intraderm
via
gene
gun
intramuscularli
depict
figur
c
respect
addit
data
suggest
immun
via
gene
gun
intramuscular
immun
gener
similar
number
cell
thu
data
indic
dna
vaccin
express
gener
higher
frequenc
activ
cell
compar
control
taken
togeth
data
indic
dna
vaccin
express
gener
detect
cell
respons
order
assess
antitumor
immun
gener
dna
vaccin
express
perform
vivo
tumor
protect
assay
mice
per
group
immun
intraderm
variou
dna
vaccin
via
gene
gun
twice
oneweek
interv
seven
day
last
immun
mice
challeng
subcutan
mous
tumor
cell
tumor
growth
monitor
visual
inspect
palpat
twice
week
shown
figur
immun
dna
vaccin
express
induc
higher
percentag
tumorfre
mice
compar
immun
dna
vaccin
order
test
therapeut
effect
vaccin
dna
vaccin
express
challeng
mice
per
group
intraven
mous
cell
three
ten
day
later
mice
treat
intraderm
variou
recombin
dna
vaccin
via
gene
gun
mice
sacrif
day
tumor
challeng
number
pulmonari
tumor
nodul
quantifi
compar
shown
figur
signific
reduct
number
pulmonari
tumor
nodul
mice
treat
dna
vaccin
express
compar
mice
treat
dna
vaccin
p
thu
taken
togeth
data
suggest
mice
vaccin
dna
vaccin
express
gener
signific
antitumor
effect
express
tumor
order
determin
antibodi
level
obtain
mice
vaccin
variou
dna
vaccin
perform
elisa
use
full
length
protein
mice
per
group
vaccin
intraderm
via
gene
gun
intramuscularli
variou
recombin
dna
vaccin
elisa
analysi
perform
determin
level
antibodi
vaccin
mice
shown
figur
b
signific
level
antibodi
respons
mice
vaccin
dna
vaccin
express
intraderm
via
gene
gun
intramuscularli
compar
mice
vaccin
dna
vaccin
express
furthermor
antibodi
respons
mice
vaccin
dna
compar
antibodi
respons
mice
vaccin
dna
p
addit
antibodi
respons
mice
vaccin
intramuscularli
compar
mice
vaccin
intraderm
thu
data
suggest
mice
vaccin
dna
vaccin
express
capabl
gener
signific
level
antibodi
vaccin
mice
order
determin
neutral
antibodi
respons
pseudovirion
infect
mice
vaccin
variou
dna
vaccin
perform
neutral
assay
use
pseudovirion
mice
per
group
vaccin
either
intraderm
via
gene
gun
intramuscularli
variou
recombin
dna
vaccin
shown
figur
b
signific
neutral
antibodi
respons
mice
vaccin
dna
vaccin
express
compar
mice
vaccin
dna
vaccin
express
p
furthermor
neutral
activ
observ
mice
vaccin
dna
compar
mice
vaccin
dna
dna
interestingli
intramuscular
administr
dna
vaccin
show
vaccin
dna
gener
slightli
lower
titer
neutral
antibodi
compar
vaccin
dna
vaccin
thu
data
suggest
dna
capabl
gener
signific
level
neutral
antibodi
respons
vaccin
mice
current
studi
creat
hpv
dna
vaccin
encod
calreticulin
link
earli
protein
late
protein
data
indic
vaccin
dna
vaccin
capabl
gener
potent
cell
immun
respons
result
signific
therapeut
effect
express
tumor
cell
furthermor
data
suggest
vaccin
gener
signific
neutral
antibodi
respons
pseudovirion
infect
thu
creat
potenti
promis
prevent
therapeut
dna
vaccin
data
serv
import
foundat
futur
clinic
translat
current
therapeut
hpv
dna
vaccin
use
clinic
grade
gene
gun
devic
prepar
phase
clinic
trial
patient
stage
posit
cervic
cancer
trimbl
person
commun
current
studi
repres
advanc
studi
use
vaccin
use
current
studi
target
well
futur
clinic
translat
necessari
address
safeti
concern
regard
potenti
oncogen
associ
administr
dna
vaccin
bodi
thu
import
use
attenu
detox
version
mutat
demonstr
mutat
posit
andor
disrupt
rb
bind
site
abolish
capac
transform
cell
furthermor
mutat
posit
shown
destroy
sever
function
prevent
mutat
protein
immort
human
epitheli
cell
construct
use
current
studi
employ
attenu
detox
form
thu
elimin
safeti
concern
may
aris
sinc
protein
repres
ideal
target
develop
hpv
therapeut
vaccin
dna
vaccin
target
may
gener
potent
immun
respons
antitumor
effect
target
either
alon
inde
previou
studi
peng
et
al
demonstr
simultan
vaccin
mice
transgen
mice
dna
vaccin
gener
signific
tcell
immun
respons
vaccin
mice
furthermor
combin
vaccin
dna
gener
significantli
better
therapeut
antitumor
effect
hpv
tumor
vaccin
either
crt
dna
dna
alon
data
suggest
may
desir
target
gener
better
therapeut
effect
express
tumor
data
gener
current
studi
suggest
gene
gunbas
immun
techniqu
may
gener
higher
number
antigenspecif
cell
compar
intramuscular
immun
particularli
case
antigen
agreement
previou
studi
trimbl
et
al
indic
vaccin
administ
via
gene
gun
gener
highest
number
antigenspecif
cell
addit
dna
vaccin
via
gene
gun
requir
least
dose
gener
similar
slightli
better
antitumor
effect
compar
needl
intramuscular
im
biojector
administr
thu
data
suggest
dna
vaccin
via
gene
gun
repres
effect
regimen
dna
administr
previou
studi
show
dna
vaccin
encod
crt
link
sever
antigen
includ
sarscov
capabl
gener
significantli
higher
level
antigenspecif
antibodi
respons
compar
dna
vaccin
encod
target
antigen
without
linkag
crt
vaccin
mice
howev
current
studi
observ
vaccin
dna
vaccin
encod
crt
link
gener
compar
level
antibodi
respons
compar
vaccin
dna
vaccin
encod
wildtyp
thu
strategi
employ
crt
enhanc
antigenspecif
antibodi
respons
dna
vaccin
clearli
depend
natur
antigen
although
crt
strategi
enhanc
antibodi
respons
improv
antigenspecif
cellmedi
immun
respons
summari
creat
prevent
therapeut
hpv
dna
vaccin
capabl
gener
signific
antigenspecif
therapeut
antitumor
effect
well
neutral
antibodi
respons
hpv
pseudovirion
preclin
observ
serv
import
foundat
futur
clinic
translat
seven
day
last
immun
mice
challeng
subcutan
mous
tumor
cell
tumor
growth
monitor
visual
inspect
palpat
twice
week
examin
kaplanmei
analysi
b
bar
graph
depict
quantif
number
pulmonari
nodul
mice
treat
variou
dna
vaccin
mice
per
group
challeng
mous
cell
via
tail
vein
three
ten
day
later
mice
treat
intraderm
variou
recombin
dna
vaccin
via
gene
gun
mice
sacrif
day
tumor
challeng
number
pulmonari
tumor
nodul
quantifi
compar
data
shown
p
one
group
mice
per
group
immun
intraderm
via
gene
gun
variou
recombin
dna
vaccin
four
time
oneweek
interv
anoth
group
mice
per
group
immun
intramuscularli
variou
recombin
dna
vaccin
four
time
oneweek
interv
elisa
analysi
perform
determin
antibodi
respons
vaccin
mice
bar
graph
depict
antibodi
respons
mice
vaccin
intraderm
variou
dna
vaccin
via
gene
gun
b
bar
graph
depict
antibodi
respons
mice
vaccin
intramuscularli
variou
dna
vaccin
result
dilut
repres
show
mean
absorb
od
nm
sd
data
collect
experi
one
repres
experi
two
perform
serum
rabbit
vaccin
standard
control
graphic
represent
neutral
activ
mice
vaccin
variou
dna
vaccin
one
set
mice
per
group
immun
intraderm
via
gene
gun
variou
recombin
dna
vaccin
four
time
oneweek
interv
anoth
set
mice
per
group
immun
intramuscularli
variou
recombin
dna
vaccin
four
time
oneweek
interv
neutral
assay
perform
use
pseudovirion
determin
neutral
antibodi
respons
vaccin
mice
antipeptid
serum
use
posit
control
antibodi
gener
neutral
respons
nonneutr
neg
control
antibodi
